Evidence map›Paper›PMID 33437504›Full record

ArticleFuture science OA2020

Survival and glycemic control in patients with coexisting lymphoma and diabetes: a case-control analysis.

Bria J Rice, Matthew R Buras, Heidi E Kosiorek, Kyle E Coppola, Shailja B Amin, Patricia M Verona, Curtiss B Cook, Nina J Karlin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future science OA, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bria J RiceDepartment of Internal Medicine, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0003-3768-6985
Matthew R BurasDepartment of Biostatistics, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0001-6503-0989
Heidi E KosiorekDepartment of Biostatistics, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0002-4651-9516
Kyle E CoppolaMayo Clinic Cancer Center, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0001-5589-293X
Shailja B AminDivision of Hematology & Medical Oncology, Mayo Clinic Hospital, Phoenix, AZ 85054, USA.ORCID https://orcid.org/0000-0002-8379-7064
Patricia M VeronaDepartment of Information Technology, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0003-2641-1986
Curtiss B CookDivision of Endocrinology, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0001-5885-9959
Nina J KarlinMayo Clinic Cancer Center, Mayo Clinic, Scottsdale, AZ 85259, USA.ORCID https://orcid.org/0000-0001-9790-0379
Mayo Clinic in Arizona · USMayo Clinic Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe examined the effect of diabetes on survival in patients with lymphoma and the effect of lymphoma on glycemic control. PATIENTS &

methodsPatients with lymphoma with and without diabetes (2005-2016) were retrospectively identified and matched 1:1. Overall survival and progression-free survival were estimated by the Kaplan-Meier method. Hemoglobin A

resultsFor patients with diabetes, mean HbA

conclusionLymphoma and its treatment did not affect glycemic control. Diabetes did not decrease lymphoma-specific survival.

Indexed as

cancerdiabetesendocrinologylymphomaoutcomes researchsurvival

Identifiers

PMID33437504
PMCPMC7787157
OpenAlexW3094672303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.